Prognostic indices for follicular lymphoma: PRIMA-PI

Prognostic indices for follicular lymphoma: PRIMA-PI

VJHemOnc

1 year
40 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Follicular lymphoma treatments are improving; however, there are subgroups of patients who still have poor outcomes. Here, Marek Trneny, MD, PhD, of Charles University, Prague, Czech Republic, evaluates different prognostic indices and their utility in follicular lymphoma management, at the 23rd Congress of the European Hematology Association (EHA) 2018, held in Stockholm, Sweden. He touches upon existing indices like FLIPI and FLIPI2, before focusing on the prognostic index developed from the PRIMA study (NCT00140582). The PRIMA-PI uses ?2-microglobulin level to categorize patients into risk level groups. Dr Trneny discusses how, after testing this index with his own group of patients, it was found to be more simple and robust than other prognostic indices, establishing it as a useful tool for directing treatment in the clinical setting.
Up Next Autoplay
CAR-T: Management of Cytokine Release Syndrome and Neurotoxicity
CAR-T: Management of Cytokine Release Syndrome and Neurotoxicity
Category: Lymphoma
1,010 Views
imedex 5 months
Update: Relapsed/Refractory Follicular Lymphoma
Update: Relapsed/Refractory Follicular Lymphoma
Category: Lymphoma
388 Views
imedex 5 months
Follicular Lymphoma: Update on Upfront and Maintenance Therapy
Follicular Lymphoma: Update on Upfront and Maintenance Therapy
Category: Lymphoma
325 Views
imedex 5 months
CAR-T in Lymphoma
CAR-T in Lymphoma
Category: Lymphoma
241 Views
imedex 5 months
Peripheral T-Cell Lymphoma: What is New on the Horizon?
Peripheral T-Cell Lymphoma: What is New on the Horizon?
Category: Lymphoma
227 Views
imedex 5 months
ASH 2016 Page 5 Update on CAR-T Cell Therapy in Lymphoma
ASH 2016 Page 5 Update on CAR-T Cell Therapy in Lymphoma
Category: Lymphoma
409 Views
cancergrace 5 months
ASH 2016 Page 4 Update on Antibody Therapies in Indolent Non-Hodgkin Lymphoma
ASH 2016 Page 4 Update on Antibody Therapies in Indolent Non-Hodgkin Lymphoma
Category: Lymphoma
187 Views
cancergrace 5 months
ASH 2016 Page 8 Leonard New Data for Mantel Cell and T-Cell Lymphoma Patients
ASH 2016 Page 8 Leonard New Data for Mantel Cell and T-Cell Lymphoma Patients
Category: Lymphoma
69 Views
cancergrace 5 months
ASH 2016  Page 7 Leonard Follicular Lymphoma Treatment Update
ASH 2016 Page 7 Leonard Follicular Lymphoma Treatment Update
Category: Lymphoma
86 Views
cancergrace 5 months
ASH 2016 Page 6 Leonard Update on Diffuse Large B Cell Lymphoma Treatments
ASH 2016 Page 6 Leonard Update on Diffuse Large B Cell Lymphoma Treatments
Category: Lymphoma
21 Views
cancergrace 5 months